Effects of Alirocumab and Evolocumab on Cardiovascular Mortality and LDL-C: Stratified According to the Baseline LDL-C Levels

Effects of Alirocumab and Evolocumab on Cardiovascular Mortality and LDL-C: Stratified According to the Baseline LDL-C Levels

Background: A meta-analysis was conducted to determine whether the cardiovascular mortality and lipid-lowering effects of alirocumab and evolocumab are influenced by various baseline low-density lipoprotein cholesterol (LDL-C) levels....

Full description

Saved in:
Bibliographic Details
Main Authors: Hui Ma, Wenfang Ma, Yang Liu, Lixing Chen, Peng Ding
Format: Article
Language:English
Published: IMR Press 2025-04-01
Series:Reviews in Cardiovascular Medicine
Subjects:
alirocumab
evolocumab
low-density lipoprotein cholesterol (ldl-c)
baseline stratification
cardiovascular mortality
lipid-lowering efficacy
Online Access:https://www.imrpress.com/journal/RCM/26/4/10.31083/RCM26980
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items